MedPath
NMPA Approval

地塞米松棕榈酸酯

国药准字H20100169

April 16, 2025

Drug Information

地塞米松棕榈酸酯

原料药

化学药品

April 16, 2025

Company Information

Applicant Company

北京市海淀区吴家村路11号

Manufacturing Company

北京市海淀区吴家村路11号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.